Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2020.10.008
Abstract: BACKGROUND Direct oral anticoagulants (DOACs) i.e. apixaban, rivaroxaban, and dabigatran are increasingly being utilized to provide prophylaxis and treatment for arterial and venous thromboembolism. While multiple procedural subspecialties have implemented guidelines detailing timeframes for perioperative… read more here.
Keywords: direct oral; doac interruption; dermatologic surgery; perioperative doac ... See more keywords